Cargando…
PRC2/EED-EZH2 Complex Is Up-Regulated in Breast Cancer Lymph Node Metastasis Compared to Primary Tumor and Correlates with Tumor Proliferation In Situ
BACKGROUND: Lymph node metastasis is a key event in the progression of breast cancer. Therefore it is important to understand the underlying mechanisms which facilitate regional lymph node metastatic progression. METHODOLOGY/PRINCIPAL FINDINGS: We performed gene expression profiling of purified tumo...
Autores principales: | Yu, Hongxiang, Simons, Diana L., Segall, Ilana, Carcamo-Cavazos, Valeria, Schwartz, Erich J., Yan, Ning, Zuckerman, Neta S., Dirbas, Frederick M., Johnson, Denise L., Holmes, Susan P., Lee, Peter P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519681/ https://www.ncbi.nlm.nih.gov/pubmed/23251464 http://dx.doi.org/10.1371/journal.pone.0051239 |
Ejemplares similares
-
Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer
por: Chen, Huiming, et al.
Publicado: (2015) -
Polycomb Repressive
Complex 2 Modulation through the
Development of EZH2–EED Interaction Inhibitors and EED Binders
por: Tomassi, Stefano, et al.
Publicado: (2021) -
Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013) -
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
por: Lee, William, et al.
Publicado: (2014) -
Discovery of selective activators of PRC2 mutant EED-I363M
por: Suh, Junghyun L., et al.
Publicado: (2019)